Enhanced Glucose Transport, but not Phosphorylation Capacity, Ameliorates Lipopolysaccharide-Induced Impairments in Insulin Stimulated-Muscle Glucose Uptake

Yolanda F. Otero, Kimberly X. Mulligan, Tammy M. Barnes, Eric A. Ford, Carlo M. Malabanan, Haihong Zong, Jeffrey E. Pessin, David H. Wasserman, Owen P. McGuinness

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

ABSTRACT: Lipopolysaccharide (LPS) is known to impair insulin stimulated muscle glucose uptake. We determined if increased glucose transport (GLUT4) or phosphorylation capacity (hexokinase II; HKII) could overcome the impairment in muscle glucose uptake (MGU). We utilized mice that over-expressed GLUT4 (GLUT4) or HKII (HK) in skeletal muscle. Studies were performed in conscious, chronically catheterized (carotid artery and jugular vein) mice. Mice received an intravenous bolus of either LPS (10?μg/g body weight) or vehicle (VEH). After 5?h, a hyperinsulinemic-euglycemic clamp was performed. As MGU is also dependent on cardiovascular function that is negatively affected by LPS, cardiac function was assessed using echocardiography. LPS decreased whole body glucose disposal and MGU in WT and HK mice. In contrast, the decrease was attenuated in GLUT4 mice. While membrane-associated GLUT4 was increased in VEH-treated GLUT4 mice, LPS impaired membrane-associated GLUT4in GLUT4 mice to the same level as LPS-treated WT mice. This suggested that overexpression of GLUT4 had further benefits beyond preserving transport activity. In fact, GLUT4 overexpression attenuated the LPS-induced decrease in cardiac function. The maintenance of MGU in GLUT4 mice following LPS was accompanied by sustained anaerobic glycolytic flux as suggested by increased muscle Pdk4 expression, and elevated lactate availability. Thus, enhanced glucose transport, but not phosphorylation capacity, ameliorates LPS-induced impairments in MGU. This benefit is mediated by long-term adaptations to the overexpression of GLUT4 that sustain muscle anaerobic glycolytic flux and cardiac function in response to LPS.

Original languageEnglish (US)
JournalShock
DOIs
StateAccepted/In press - Dec 14 2015

Fingerprint

Lipopolysaccharides
Phosphorylation
Insulin
Glucose
Muscles
Hexokinase
Glucose Clamp Technique
Membranes
Jugular Veins
Carotid Arteries
Echocardiography
Lactic Acid
Skeletal Muscle
Body Weight
Maintenance

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine
  • Emergency Medicine

Cite this

Enhanced Glucose Transport, but not Phosphorylation Capacity, Ameliorates Lipopolysaccharide-Induced Impairments in Insulin Stimulated-Muscle Glucose Uptake. / Otero, Yolanda F.; Mulligan, Kimberly X.; Barnes, Tammy M.; Ford, Eric A.; Malabanan, Carlo M.; Zong, Haihong; Pessin, Jeffrey E.; Wasserman, David H.; McGuinness, Owen P.

In: Shock, 14.12.2015.

Research output: Contribution to journalArticle

Otero, Yolanda F. ; Mulligan, Kimberly X. ; Barnes, Tammy M. ; Ford, Eric A. ; Malabanan, Carlo M. ; Zong, Haihong ; Pessin, Jeffrey E. ; Wasserman, David H. ; McGuinness, Owen P. / Enhanced Glucose Transport, but not Phosphorylation Capacity, Ameliorates Lipopolysaccharide-Induced Impairments in Insulin Stimulated-Muscle Glucose Uptake. In: Shock. 2015.
@article{e072a827006841ce9c0ed12f8eb06798,
title = "Enhanced Glucose Transport, but not Phosphorylation Capacity, Ameliorates Lipopolysaccharide-Induced Impairments in Insulin Stimulated-Muscle Glucose Uptake",
abstract = "ABSTRACT: Lipopolysaccharide (LPS) is known to impair insulin stimulated muscle glucose uptake. We determined if increased glucose transport (GLUT4) or phosphorylation capacity (hexokinase II; HKII) could overcome the impairment in muscle glucose uptake (MGU). We utilized mice that over-expressed GLUT4 (GLUT4) or HKII (HK) in skeletal muscle. Studies were performed in conscious, chronically catheterized (carotid artery and jugular vein) mice. Mice received an intravenous bolus of either LPS (10?μg/g body weight) or vehicle (VEH). After 5?h, a hyperinsulinemic-euglycemic clamp was performed. As MGU is also dependent on cardiovascular function that is negatively affected by LPS, cardiac function was assessed using echocardiography. LPS decreased whole body glucose disposal and MGU in WT and HK mice. In contrast, the decrease was attenuated in GLUT4 mice. While membrane-associated GLUT4 was increased in VEH-treated GLUT4 mice, LPS impaired membrane-associated GLUT4in GLUT4 mice to the same level as LPS-treated WT mice. This suggested that overexpression of GLUT4 had further benefits beyond preserving transport activity. In fact, GLUT4 overexpression attenuated the LPS-induced decrease in cardiac function. The maintenance of MGU in GLUT4 mice following LPS was accompanied by sustained anaerobic glycolytic flux as suggested by increased muscle Pdk4 expression, and elevated lactate availability. Thus, enhanced glucose transport, but not phosphorylation capacity, ameliorates LPS-induced impairments in MGU. This benefit is mediated by long-term adaptations to the overexpression of GLUT4 that sustain muscle anaerobic glycolytic flux and cardiac function in response to LPS.",
author = "Otero, {Yolanda F.} and Mulligan, {Kimberly X.} and Barnes, {Tammy M.} and Ford, {Eric A.} and Malabanan, {Carlo M.} and Haihong Zong and Pessin, {Jeffrey E.} and Wasserman, {David H.} and McGuinness, {Owen P.}",
year = "2015",
month = "12",
day = "14",
doi = "10.1097/SHK.0000000000000550",
language = "English (US)",
journal = "Shock",
issn = "1073-2322",
publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Enhanced Glucose Transport, but not Phosphorylation Capacity, Ameliorates Lipopolysaccharide-Induced Impairments in Insulin Stimulated-Muscle Glucose Uptake

AU - Otero, Yolanda F.

AU - Mulligan, Kimberly X.

AU - Barnes, Tammy M.

AU - Ford, Eric A.

AU - Malabanan, Carlo M.

AU - Zong, Haihong

AU - Pessin, Jeffrey E.

AU - Wasserman, David H.

AU - McGuinness, Owen P.

PY - 2015/12/14

Y1 - 2015/12/14

N2 - ABSTRACT: Lipopolysaccharide (LPS) is known to impair insulin stimulated muscle glucose uptake. We determined if increased glucose transport (GLUT4) or phosphorylation capacity (hexokinase II; HKII) could overcome the impairment in muscle glucose uptake (MGU). We utilized mice that over-expressed GLUT4 (GLUT4) or HKII (HK) in skeletal muscle. Studies were performed in conscious, chronically catheterized (carotid artery and jugular vein) mice. Mice received an intravenous bolus of either LPS (10?μg/g body weight) or vehicle (VEH). After 5?h, a hyperinsulinemic-euglycemic clamp was performed. As MGU is also dependent on cardiovascular function that is negatively affected by LPS, cardiac function was assessed using echocardiography. LPS decreased whole body glucose disposal and MGU in WT and HK mice. In contrast, the decrease was attenuated in GLUT4 mice. While membrane-associated GLUT4 was increased in VEH-treated GLUT4 mice, LPS impaired membrane-associated GLUT4in GLUT4 mice to the same level as LPS-treated WT mice. This suggested that overexpression of GLUT4 had further benefits beyond preserving transport activity. In fact, GLUT4 overexpression attenuated the LPS-induced decrease in cardiac function. The maintenance of MGU in GLUT4 mice following LPS was accompanied by sustained anaerobic glycolytic flux as suggested by increased muscle Pdk4 expression, and elevated lactate availability. Thus, enhanced glucose transport, but not phosphorylation capacity, ameliorates LPS-induced impairments in MGU. This benefit is mediated by long-term adaptations to the overexpression of GLUT4 that sustain muscle anaerobic glycolytic flux and cardiac function in response to LPS.

AB - ABSTRACT: Lipopolysaccharide (LPS) is known to impair insulin stimulated muscle glucose uptake. We determined if increased glucose transport (GLUT4) or phosphorylation capacity (hexokinase II; HKII) could overcome the impairment in muscle glucose uptake (MGU). We utilized mice that over-expressed GLUT4 (GLUT4) or HKII (HK) in skeletal muscle. Studies were performed in conscious, chronically catheterized (carotid artery and jugular vein) mice. Mice received an intravenous bolus of either LPS (10?μg/g body weight) or vehicle (VEH). After 5?h, a hyperinsulinemic-euglycemic clamp was performed. As MGU is also dependent on cardiovascular function that is negatively affected by LPS, cardiac function was assessed using echocardiography. LPS decreased whole body glucose disposal and MGU in WT and HK mice. In contrast, the decrease was attenuated in GLUT4 mice. While membrane-associated GLUT4 was increased in VEH-treated GLUT4 mice, LPS impaired membrane-associated GLUT4in GLUT4 mice to the same level as LPS-treated WT mice. This suggested that overexpression of GLUT4 had further benefits beyond preserving transport activity. In fact, GLUT4 overexpression attenuated the LPS-induced decrease in cardiac function. The maintenance of MGU in GLUT4 mice following LPS was accompanied by sustained anaerobic glycolytic flux as suggested by increased muscle Pdk4 expression, and elevated lactate availability. Thus, enhanced glucose transport, but not phosphorylation capacity, ameliorates LPS-induced impairments in MGU. This benefit is mediated by long-term adaptations to the overexpression of GLUT4 that sustain muscle anaerobic glycolytic flux and cardiac function in response to LPS.

UR - http://www.scopus.com/inward/record.url?scp=84950120104&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84950120104&partnerID=8YFLogxK

U2 - 10.1097/SHK.0000000000000550

DO - 10.1097/SHK.0000000000000550

M3 - Article

C2 - 26682946

AN - SCOPUS:84950120104

JO - Shock

JF - Shock

SN - 1073-2322

ER -